The proposed iterative 4D CBCT reconstruction algorithm is more than an order of magnitude faster than other iterative algorithms described in the literature. It produces sharp, streak free images from standard 60s acquisitions used for 3D CBCT. For purposes such as patient setup and verification of tumour motion, the fast reconstruction algorithm presented enables online usage of 4D CBCT as a part of the clinical treatment routine.
Purpose or Objective: Radiotherapy treatment planning for use with high-energy photon beams currently employs a binary approach when defining the PTV. Current approach using van Herk's 3D margin recipe (VHMR) may require additional modifications if the PTV overlaps with OARs. Our novel approach aims to move away from the binary treatment of PTVs, where each voxel is categorised as either target or non-target, and generate PTVs with voxels that may be considered part PTV and part OAR, providing the optimiser with additional information to more easily tackle conflicting dose constraints. We investigate the impact of this novel approach when applied to prostate radiotherapy treatments, and compare treatment plans generated using our approach and VHMR.
Material and Methods:
Following the principles laid out in VHMR, only geometrical uncertainties are considered. We explore the use of 2D margins, motivated by the fact that small displacements in beam direction result in negligible change in dose delivered to the target. Only uncertainties perpendicular to the incident beam direction are considered, and therefore safety margins are generated for each beam direction. The degree of overlap of these beam specific margins is normalised and used to assign a weighting factor defined as the ratio of target-to-OAR content to a specific voxel. The objective function employed in the inverse planning process uses these local weighting factors for voxels of the CTV and OAR, should an overlap occur. Five prostate radiotherapy plans were generated using IMRT inverse planning. The prostate was given a prescription of 78Gy in 2Gy fractions. Systematic uncertainties of 1.1mm, 1.1mm and 1.5mm in the LR, SI and AP directions, respectively, and 2.2mm, 2.1mm, 3.2mm for the random uncertainties, were used. Plans were generated such that the static dose distribution conforms to requirements outlined in the PACE clinical trial. A verification tool was used to perform Monte Carlo simulations to model the cumulative dose of the ROI when it is displaced due to the presence of uncertainties; statistics from the tool are used for plan comparison.
Results:
We used a population of 50,000 for simulation. We observed a median of 96.7% and 100% of the population CTV receiving D98% > 95% Dpres for our approach and VHMR respectively. Both values are higher than the 90% population requirement as stated in the VHMR derivation, and this is a direct consequence of the imperfect conformality of the dose distribution. When looking at rectal doses, we observed an improvement of 20.2% to 89.2% of the population satisfying D2% < 70Gy using our method; table 1 shows the results of the simulation for the CTV, rectum and bladder for all 5 patients.
Conclusion:
We observed a significant decrease of high rectal doses delivered whilst maintaining sufficient dose coverage of the CTV, though the amount of sparing depends largely on the patient's anatomy and the objectives chosen for optimisation.
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